Titterton Lewis H jr 4

What Happened
Lewis H. Titterton Jr, a director of Anixa Biosciences, purchased 2,797 shares of ANIX on 2026-07-15 via an open-market/private purchase (transaction code P) at $3.28 per share, a total cost of about $9,174. The Form 4 reporting the trade was filed on 2026-07-16.

Key Details

• Transaction date: 2026-07-15; Form 4 filed: 2026-07-16 (appears timely).
• Price and size: 2,797 shares at $3.28 each; total ≈ $9,174.
• Transaction code: P (purchase — open market or private purchase).
• Shares owned after transaction: Not specified in the provided data.
• Footnotes/plan: No 10b5-1 plan, tax withholding, or other special footnotes reported in the provided details.
• Filing accession: 0001493152-26-033461 (period of report: 2026-07-15).

Context
Insider purchases can be informative to investors because they involve insiders putting personal capital into the company; this particular buy is modest in size (~$9.2k). This summary is factual only — it does not speculate on the director’s motives. If you want, I can check the full Form 4 to pull the post-transaction ownership figure or any additional filing notes.